Read + Share
D'Haens G, Panes J, Louis E, Lacerda A, et al. Upadacitinib Was Efficacious and Well-tolerated Over 30 Months in Patients With
Crohn's Disease in the CELEST Extension Study. Clin Gastroenterol Hepatol 2022;20:2337-2346.
PMID: 34968730
|
 |
|
D'Haens G, Panes J, Louis E, Lacerda A, et al. Upadacitinib Was Efficacious and Well-tolerated Over 30 Months in Patients With
Crohn's Disease in the CELEST Extension Study. Clin Gastroenterol Hepatol 2022;20:2337-2346.
PMID: 34968730
|
|
|
|